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INTRODUCTION:
Ventilator Associated Pneumonia (VAP), one of
Healthcare Acquired Infections (HAIs) associated with
intensive care units (ICU) of hospitals is a major challenge
for health professionals these days. It is one of the most
common hospital infections among the ventilated
patients1, 2, 3. It has serious implication as it continues
to pose potentially fatal complication of ventilation
care4.It results in load on health resources associated
with increase morbidity and mortality.5,6,7,8,9
VAP is further divided into two; early- onset pneumonia
(That occurs within 48-72 hours) and late-onset
pneumonia (72 hours or more after intubation). Incidence
of pneumonia varies from 9% to 68%9 and 90% of all
HAIs in mechanically ventilated patients are attributed
to VAP.10  Increase prevalence of VAP is associated with
the following risk factors identified by various studies.
Most common microorganisms include Streptococcus
pneumoniae, Haemophilusinfluenzae, and Moraxella
catarrhalis. Late-onset VAP occurs 5 or more days after
i n t u b a t i o n .  S t a p h y l o c o c c u s  a u r e u s ,
Acinetobacterbaumannii, Pseudomonas aeruginosa,
Klebsiellapneumoniae, and Enterobacter are some of the
most prevalent microorganisms reported for late-onset
VAP.
Common risk factors for VAP include; supine position,
endotracheal, nasogastric and enteral feeding tubes,
sedation, impaired mental status, poor oral hygiene,
gastric alkalization, inadequate hand washing, period of
mechanical ventilation, prolonged antibiotic use,
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preexisting comorbidities, invasive procedure, hospital
environment and contact with other.11
There were various strategies applied for the prevention
of VAP but no single strategy was effective in reducing
VAP significantly. Hence a number of strategies identified
to be implemented. Grap and Munro 1997 demonstrated
that a supine position instead of elevation of head of bed
(HOB) increased the chances of VAP.12
Evidence based guidelines for the prevention of VAP
have been developed in North America by CDC.13
This ventilator care bundle included four elements;
1.Elevation of head of bed to 30-450
2.Daily Sedation hold.
3.Deep vein thrombosis (DVT) prophylaxis.
4.Gastric ulcer (GU) prophylaxis.
This care bundle was updated in July 2007 and now
includes some more strategies like appropriate
humidification of inspired gases and tubing
management.Various studies have been conducted in the
western countries to evaluate the compliance and
effectiveness of VAP care bundle 14,15,16,17 but only one
such study conducted in this part of world, having
different, geopolitical, social and health environment at
the time of initiating of project18. This study was designed
in order to evaluate the effectiveness and compliance of
VAP care bundle in local setting at Erfan&Bagedo General
hospital, Jeddah, KSA and to compare the VAP rate with
compliance rate.
MATERIALS AND METHODS:
This is a Quasi experimental before and after observation
type of study, in which VAP care bundle was implemented
to the ventilated patients without any control group. It
was conducted in Erfan&Bagedo General Hospital,
Jeddah, which is a long term chronic care hospital
consisting of 22 ICU beds with patient/Nurse ratio as 2-
3 to 1. All the patients who were kept on ventilator for
more than 24 hours were included in the study. Following
steps were taken to ensure the reliability and validity
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1.  CDC definition of VAP was used to define the case.
2.  Implementation of standard template for VAP care
bundle.
3. Daily compliance monitoring by the principal
investigator.
4.  Training of involved staff.
5.  Pilot study was done to find out the difficulty in VAP
care bundle implementation and  factors that could
increase compliance.
Method of data collection:
A meeting was held with the head of ICU and ICU head
nurse to discuss the implementation of VAP bundle and
explore the role of physicians and nurses (formation of
VAP care bundle team).
•  Principal Investigator himself trained all the nurses
working in the ICU of hospital, regarding HII strategy.
•  VAP care bundle elements were selected by infection
control team, based on extensive literature review and
consisting of the following elements:
1.  Elevation of the Head of The bed between 30-40
degrees.
2.  Daily Sedation vacations of assessment of readiness
to extubate.
3.  PUD prophylaxis.
4.  DVT prophylaxis.
5.  Proper subglottic suctions.
6.  Optimal oral care with chlorhexidine.
VAP care bundle lecture was given to the ICU staff
(physicians & nurses). Introduction was done, the care
bundle elements were explained and questions
answered.Date to start implementing the VAP bundle
was proposed after getting the approval from the infection
control committee and ethical committee of the
hospital.Revision of the implementation of the care bundle
to be done after six month or when required.It was decided
to assess the effect of the VAP care bundle implementation
on the reduction of VAP rate to be looked at after 12
months.
Statistical analysis:
SPSS software ver. 13 was used to analyze the data.
Confidence interval was set at 95% and a p value < 0.05
was considered as statistically significant. The VAP rate
was compared with CDC National Health Care Safety
Network (NHSN) data which was reported as 0.6/1000
ventilator days19.
RESULTS:
Out of a total of 3011 patient ventilator days, 18 patient
developed VAP. Some of the patients were readmitted
more than once. The range of age was from 16 to 95
years with Mean as 63.5, Mode 70, Median 66 and
standard deviation as 18.9. Twelve (66.6%) of them were
male. Most common co-morbidities were hypertension
and diabetes and the most common organisms found
were Acinetobacterbaumanniiand Pseudomonas
aeruginosa (Table 1).
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Regarding VAP care bundle observations, the range
included minimum of 161 and maximum of 343 from
February 2010 to January 2011 (Table 2).
Number of VAP care bundle implementation increased
from 42 (17.36%) in the month of February 2010 to 315
(91.8%) in the month of October 2010. However the
implementation rate was 100% for the months of
November, December 2010 and January 2011. VAP rate
dropped from 8.85/1000 ventilator days in the month of
February 2010 to 3.15 in January 2011 (Fig 1).
DISCUSSION:
The ventilator Associated Pneumonia Care Bundle (VAP
care bundle) strategy was designed to reduce the VAP rate
and improve the health care of the ventilated patient. The
current strategy demonstrates that VAP care bundle
approach has shown strong association with the VAP rate.
There was significant negative correlation between
percentage of application of VAP care bundle and VAP
rate. In the present study, the mean age of the patients was
63.5± 18.9. Male: Female ratio was 2:1.The total ventilation
days were 3011. Most of the studies did not report
demographic characteristics of studied population. However
Bukhari has documented a total ventilation days during
their one year study period as equal to 27 47 18.  We had
a total of 18 patients identified during the study period.
Some of the patients were admitted more than once.
Most common co-morbidities identified were hypertension
and diabetes.Most common organisms identified in this
study were Acinetobacterbaumannii (28.6%) and
Pseudomonas aeruginosa (25.0%). Allan2 found the same
two pathogens as the leading isolates with Pseudomonas
aeruginosa as 29% and Acinetobacterbaumannii as 27 %.
Bukhari also found the same two organisms as the two
most frequent isolates Pseudomonas aeruginosa 30.8%
and Acinetobacterbaumannii as 27.7 % respectively.
Regarding VAP care bundle compliance rate, it started
with 17.36% and reached to 100% within 9 months.
Bukhari has reported 100% compliance within 6 months,
probably because of the reason that they started with 30%
compliance rate right from the start of study. In the current
study the VAP rate at the beginning of the study was
8.85/1000 ventilator days which decreased to 3.15 at the
end of study with a mean rate of 5.36/1000. Thus a
reduction of 5.7 per 1000(64.4%) was observed in this
study Bukhari found a decrease of 1.41/1000 ventilator
days. However the percentage reduction was less (41.6%)
than our result. They started their study with a lower
baseline VAP rate of 3.39 and achieved a rate of 1.98/
1000 after one year implementation of VAP care
bundle.18,19
Youngquist had similar findings for Maxcy Hospital where
VAP rate dropped from 6.1/ 1000 to 2.7 per 1000
ventilator days. A reduction of 4.3/1000 (70.5%) ventilator
days.20Resor reported a decrease in VAP rate from 6.6
to 2.7/1000. The percentage of reduction observed was
59.1%.21  Allan observed a decrease of VAP rate from
3.8 to 1.67 case per thousand (a 56% decrease in VAP
rate).2 More recent studies also showed a decrease of
more than 50 % in the VAP rate after successful
implementation of VAP care bundle strategy 22,23,24,25,26.
It was estimated that each VAP case was responsible for
10 hospital days with a mean cost of $ 40000. 15 A
decrease of 5.7 per thousand days will save a sum of $
228000 and for 3011 days it will be $ 686508.There was
a strong negative correlation between proportion of
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implementation of VAP care bundle and VAP rate (r= -
0.534 p value=0.037 for one tailed test).The main
limitation of the study was a lack of control group for
the purpose of comparison and for establishment of
causality.
CONCLUSION:
The implementation of VAP care bundle has significant
negative correlation with the VAP rate.Adopting VAP
care bundle approach may help in reducing the morbidity
and mortality in the ventilated patients. However a clinical
trial with appropriate control should be conducted in
order to establish causal relationship between the
compliance rate of VAP care bundle and VAP rate.
Table 1
Demography, associated co-morbid diseases and microorganisms for study population
Gender:  M=male; F= female
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Table 2
VAP Care Bundle Implementation Report
February 2010 - January 2011
Fig 1:
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